Medindia neither buys nor sells drugs. Prasugrel (Prasusafe (10 mg)) is a platelet aggregation inhibitor, prescribed for thrombotic cardiovascular (CV) events (life-threatening problems with the ...

Roe said the trial's low prasugrel dosage for the elderly stemmed from concerns in the previous TRITON-TIMI 38 trial of high-risk ACS patients slated for PCI, in which 10-mg/day prasugrel ...

Randomized to one of three arms, patients continued with clopidogrel, were switched to prasugrel 10 mg without a loading dose, or were switched to prasugrel 10 mg after receiving a 60-mg loading ...

The patients, all of whom had high on-treatment platelet reactivity (> 450 area under the curve [AUC] of AU/min) were randomized to double-dose clopidogrel (150 mg/day; n = 16) or prasugrel (10 mg/day ...

In the primary analysis of the trial, prasugrel (10 mg daily) was compared with clopidogrel (75 mg daily) in 7243 ACS patients younger than age 75. At 17 months, the rate of CV death, MI ...

In their study, the strategy of 1 month of aspirin 100 mg plus prasugrel 10 mg, followed by prasugrel 5 mg thereafter, was directly compared against the approach of aspirin 100 mg plus prasugrel ...

After PCI, patients received maintenance doses of either prasugrel (10 mg) or clopidogrel (75 mg) daily. Use of aspirin was required, and a daily dose of 75 to 162 mg was recommended. Study visits ...

is a Korean trial in which 656 East Asian ACS patients were randomised 1:1 to either a 1-month DAPT with aspirin 100 mg and prasugrel 10 mg (patients ≥75 years or body weight <60 kg received 5 ...

Prasugrel (Prasurel (10 mg)) is a platelet aggregation inhibitor, prescribed for thrombotic cardiovascular (CV) events (life-threatening problems with the heart and blood vessels), in patients who ...

In this double-blind, randomized trial, in a primary analysis involving 7243 patients under the age of 75 years receiving aspirin, we evaluated up to 30 months of treatment with prasugrel (10 mg ...